11. First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors. (22nd September 2021) Authors: Do, Khanh T.; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E.; Burris, Howard; Robert, Francisco; Camidge, D. Ross; Steuer, Conor E.; Strickler, John H.; Weise, Amy; Specht, Jennifer M.; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A. Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Global Implementation of Precision Oncology. (2021) Authors: Yam, Clinton; Ma, Brigette B. Y.; Yap, Timothy A. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Improving attribution of adverse events in oncology clinical trials. (June 2019) Authors: George, Goldy C.; Barata, Pedro C.; Campbell, Alicyn; Chen, Alice; Cortes, Jorge E.; Hyman, David M.; Jones, Lee; Karagiannis, Thomas; Klaar, Sigrid; Le-Rademacher, Jennifer G.; LoRusso, Patricia; Mandrekar, Sumithra J.; Merino, Diana M.; Minasian, Lori M.; Mitchell, Sandra A.; Montez, Sandra; O'... Journal: Cancer treatment reviews Issue: Volume 76(2019) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly(ADP‐ribose) polymerase proteins inhibitors for solid tumours. (23rd March 2023) Authors: Almanza‐Huante, Emmanuel; Bataller, Alex; Urrutia, Samuel; Gener‐Ricos, Georgina; Briski, Robert Edward; Kanagal‐Shamanna, Rashmi; Lu, Karen H.; Westin, Shannon N.; Yap, Timothy A.; Takahashi, Koichi; Ravandi, Farhad; Alvarado, Yesid; Kadia, Tapan; Sasaki, Koiji; Kantarjian, Hagop M.; Garcia‐Mane... Journal: British journal of haematology Issue: Volume 201:Number 3(2023) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha-Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric-Bernstam, Funda; Shih, Ya-Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials. (21st April 2021) Authors: Huey, Ryan W.; George, Goldy C.; Phillips, Penny; White, Revenda; Fu, Siqing; Janku, Filip; Karp, Daniel D.; Naing, Aung; Piha‐Paul, Sarina; Subbiah, Vivek; Tsimberidou, Apostolia M.; Pant, Shubham; Yap, Timothy A.; Rodon, Jordi; Meric‐Bernstam, Funda; Shih, Ya‐Chen Tina; Hong, David S. Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?. (September 2017) Authors: Capelan, Marta; Roda, Desamparados; Geuna, Elena; Rihawi, Karim; Bodla, Shankar; Kaye, Stan B.; Bhosle, Jaishree; Banerji, Udai; O'Brien, Mary; de Bono, Johann S.; Popat, Sanjay; Yap, Timothy A. Journal: Lung cancer Issue: Volume 111(2017) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes. (9th February 2022) Authors: Yap, Timothy A.; Hamilton, Erika; Bauer, Todd; Dumbrava, Ecaterina E.; Jeselsohn, Rinath; Enke, Aaron; Hurley, Sabrina; Lin, Kevin K.; Habeck, Jenn; Giordano, Heidi; Shapiro, Geoffrey I. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Precision oncology: East meets West. Issue 9 (4th January 2018) Authors: Subbiah, Vivek; Rodon, Jordi; Yap, Timothy A. Journal: International journal of cancer Issue: Volume 142:Issue 9(2018) Page Start: 1734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗